MetLife (MET) director adds 20 shares via deferred dividend reinvestment

Rhea-AI Filing Summary

MetLife Inc. director Christian Stephane Mumenthaler reported an acquisition of 20 shares of MetLife common stock on a grant/award basis at $85.57 per share. The footnote explains this was an imputed reinvestment of dividends on deferred shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Following this transaction, he directly holds 2,865 shares of MetLife common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Mumenthaler Christian Stephane

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	20	$85.57	$2K

Holdings After Transaction: Common Stock — 2,865 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares acquired: 20 shares Price per share: $85.57 per share Shares held after transaction: 2,865 shares

3 metrics

Shares acquired 20 shares Grant/award acquisition on common stock

Price per share $85.57 per share Value used for award on 20 shares

Shares held after transaction 2,865 shares Direct holdings of MetLife common stock

Key Terms

MetLife Deferred Compensation Plan for Non-Management Directors, deferred shares, imputed reinvestment of dividends

3 terms

MetLife Deferred Compensation Plan for Non-Management Directors financial

"Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors."

deferred shares financial

"Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred."

Deferred shares are a class of stock whose economic benefits or certain shareholder rights are delayed or paid later than ordinary shares—for example, dividends may be paid only after other shareholders receive theirs, or voting or redemption rights may be postponed. For investors, that timing difference matters because deferred shares typically offer lower near-term income and different risk, affecting expected returns, priority in payouts, and the share’s market value; think of them like a delayed paycheck compared with a regular salary.

imputed reinvestment of dividends financial

"Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors."

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mumenthaler Christian Stephane

(Last) (First) (Middle)

METLIFE, INC.

200 PARK AVENUE

(Street)

NEW YORK NEW YORK 10166

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
METLIFE INC [ MET ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/09/2026		A(1)		20	A	$85.57	2,865	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Remarks:

	/s/ Morgan Keehner-Jones Mayes, Attorney-in-fact	06/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did MetLife (MET) disclose for Christian Stephane Mumenthaler?

MetLife disclosed that director Christian Stephane Mumenthaler acquired 20 shares of MetLife common stock. The shares were received as a grant or award tied to imputed reinvestment of dividends on deferred shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

At what price were the new MetLife (MET) shares attributed to Christian Mumenthaler?

The 20 MetLife shares acquired by Christian Mumenthaler were recorded at a price of $85.57 per share. This price reflects the value used for the imputed reinvestment of dividends on deferred shares pursuant to the company’s Deferred Compensation Plan for Non-Management Directors.

How many MetLife (MET) shares does Christian Mumenthaler hold after this Form 4 transaction?

After the reported acquisition, Christian Mumenthaler directly holds 2,865 shares of MetLife common stock. This total includes the 20 shares received through imputed dividend reinvestment on deferred shares as described in the MetLife Deferred Compensation Plan for Non-Management Directors.

What is the nature of the MetLife (MET) shares acquired by Christian Mumenthaler on this Form 4?

The shares reflect an imputed reinvestment of dividends on deferred shares, not an open-market purchase. According to the footnote, they arise from the MetLife Deferred Compensation Plan for Non-Management Directors, where payable MetLife common stock is deferred at the director’s election.

Does the MetLife (MET) Form 4 for Christian Mumenthaler involve derivative securities?

The Form 4 shows only a non-derivative transaction in MetLife common stock for Christian Mumenthaler. The derivative summary section is empty, indicating no options, warrants, or other derivative securities were reported as part of this specific insider filing.

How is the MetLife (MET) Deferred Compensation Plan described in this insider filing?

The filing describes imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent MetLife common stock that has become payable to the director, but whose actual receipt has been deferred under the plan’s terms.